Skip to main content
SciSparc Ltd. logo

SciSparc Ltd. — Investor Relations & Filings

Ticker · SPRC ISIN · US88339A3023 US Manufacturing
Filings indexed 554 across all filing types
Latest filing 2026-05-11 Foreign Filer Report
Country US United States of America
Listing US SPRC

About SciSparc Ltd.

https://scisparc.com/

SciSparc Ltd. is a specialty clinical-stage pharmaceutical company that develops therapies for central nervous system (CNS) disorders. The company focuses on creating and enhancing a portfolio of technologies and assets based on proprietary cannabinoid pharmaceuticals. Its drug development pipeline includes candidates in clinical and pre-clinical stages targeting conditions such as Tourette Syndrome, Autism Spectrum Disorder, Alzheimer's disease and agitation, Obstructive Sleep Apnea, Status Epilepticus, and chronic pain. SciSparc's approach utilizes the biochemistry of receptors that modulate the central nervous system to create its therapeutic compounds.

Recent filings

Filing Released Lang Actions
6-K - SciSparc Ltd. (0001611746) (Filer)
Foreign Filer Report
2026-05-11 English
20-F - SciSparc Ltd. (0001611746) (Filer)
Annual Report
2026-04-29 English
3 - SciSparc Ltd. (0001611746) (Issuer)
Director's Dealing
2026-03-23 English
6-K Filing
Foreign Filer Report
2026-02-17 English
6-K Filing
Foreign Filer Report
2026-02-12 English
6-K Filing
Foreign Filer Report
2026-02-04 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.